Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2,811.00 |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | -3,811.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,811.00 |
| Dec 31, 2025 | 18,238.00 |
| Sep 30, 2025 | -5,139.00 |
| Jun 30, 2025 | -2,302.00 |
| Mar 31, 2025 | 4,361.00 |
| Dec 31, 2024 | -14,224.00 |
| Sep 30, 2024 | 21,710.00 |
| Jun 30, 2024 | 276.00 |
| Mar 31, 2024 | -8,877.00 |
| Dec 31, 2023 | 31,749.00 |
| Sep 30, 2023 | -21,217.00 |
| Jun 30, 2023 | -16,814.00 |
| Mar 31, 2023 | -1,616.00 |
| Dec 31, 2022 | -27,769.00 |
| Sep 30, 2022 | -4,108.00 |
| Jun 30, 2022 | 15,024.00 |
| Mar 31, 2022 | 2,701.00 |
| Dec 31, 2021 | -2,250.00 |
| Sep 30, 2021 | 3,525.00 |